Qingdao Vland Biotech INC. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 879.64 million compared to CNY 829.41 million a year ago. Revenue was CNY 879.64 million compared to CNY 829.41 million a year ago.

Net income was CNY 55.32 million compared to CNY 54.21 million a year ago. Basic earnings per share from continuing operations was CNY 0.22 compared to CNY 0.22 a year ago. Diluted earnings per share from continuing operations was CNY 0.22 compared to CNY 0.22 a year ago.